Cargando…
Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
BACKGROUND: Low circulating brain derived neurotrophic factor may promote cognitive deterioration, but the effects of neurotrophic and combination drug therapies on serum brain derived neurotrophic factor were not previously investigated in Alzheimer’s disease. METHODS: We evaluated the effects of C...
Autores principales: | Alvarez, X. Anton, Alvarez, Irene, Iglesias, Olalla, Crespo, Ignacio, Figueroa, Jesus, Aleixandre, Manuel, Linares, Carlos, Granizo, Elias, Garcia-Fantini, Manuel, Marey, Jose, Masliah, Eliezer, Winter, Stefan, Muresanu, Dafin, Moessler, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926802/ https://www.ncbi.nlm.nih.gov/pubmed/27207906 http://dx.doi.org/10.1093/ijnp/pyw024 |
Ejemplares similares
-
Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020) -
Modulation of Amyloid-β and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil
por: Alvarez, X. Anton, et al.
Publicado: (2022) -
Efficacy and safety of Cerebrolysin in
patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010) -
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014) -
Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
por: Muresanu, Dafin F., et al.
Publicado: (2016)